Quantitative Cyclin D1 Expression Is a Prognostic Indicator in Patients with Mantle Cell Lymphoma.
A Siddon, R Torres, H Rinder, B Smith, J Howe, C Tormey - Yale University School of Medicine, New Haven, CT
CD5-Positive MALT Lymphoma: A Clinicopathologic Study of 9 Cases.
J Jasso, L Chen, P Lin, S Li, RN Miranda, LJ Medeiros, CC Yin - UT MD Anderson Cancer Center, Houston, TX; UT Medical School, Houston, TX
Primary Follicular Lymphoma of the Small Intestine: A Morphologic, Immunohistochemical and Molecular Study of 7 Cases.
C Martin, R Kitagawa, H Garcia Rivello, D Kohan, E Mocetti, M Narbaitz - Hematopathology Consultation, La Plata, Argentina; Hospital Italiano, Buenos Aires, Argentina; National Academy of Medicine & Fundaleu, Buenos Aires, Argentina
Thymic Extranodal Marginal Zone B Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Occurs in Patients without History of Autoimmune Disease, and Is Rarely Involved by MALT Lymphoma-Associated Genetic Alterations: Analysis of 6 Cases.
HJ Cho, H Go, JH Paik, KC Jung, CW Kim, YK Jeon - Seoul National University Hospital College of Medicine, Republic of Korea
The Role of IGH and IGK Clonality Testing in Diagnostic Work-Up of Suspected Gastric Mucosa Associated Lymphoid Tissue (MALT) Lymphomas.
B Graber, H Ratech, Q Pan, J Du, S Shen, Y Lo, C McMahon - Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
Can CD123 Immunohistochemical Stain for Plasmacytoid Dendritic Cells Be Used as an Adjunctive Diagnostic Marker in Marginal Zone Lymphomas at Different Sites?
R Batra, V Ghali - St Luke's Roosevelt Hospital Center and Beth Medical Center, New York
Follicular Lymphoma "In Situ" and with Partial Lymph Node Involvement Represent Genetically Early Stages of Follicular Lymphoma Development.
P Adam, I Salaverria, I Bonzheim, MA Piris, S Montes-Moreno, F Fend, R Siebert, L Quintanilla-Martinez - Eberhard-Karls-University, Tubingen, Germany; Christian-Albrechts-University, Kiel, Germany; Spanish National Cancer Center, Madrid, Spain
Prevalent Expression of IL-21 Receptor in Follicular Lyphoma and Potential Association with Poor-Outcome Disease.
S Sikdar, B Wood, A Alhejaily, T Baetz, D LeBrun - Queen's University, Kingston, ON, Canada; Kingston General Hospital, ON, Canada
CD23 and TRAF1 Expression and Lack of BCL2/IGH Fusion Help Discriminate Primary Mediastinal Large B-Cell Lymphoma from Mediastinal Involvement by Systemic DLBCL.
LN Dao, ME Law, GS Nowakowski, WR Macon - Mayo Clinic, Rochester, MN
Jun B Expression Is Associated with Non-GC (Germinal Center) B Cell Differentiation Immunophenotype, and Jun B and Jun D with High Proliferation of Tumor Cells in DLBCL.
A Papoudou-Bai, A Batistatou, E Hatzimichael, A Dasoula, P Kanavaros, V Malamou-Mitsi - Medical School, University of Ioannina, Greece
Differential Expression of RanGAP1 between Reactive and Neoplastic B-Cell Proliferations: Using Comparative Proteomics to Search Lymphoma Biomarker and Its Clinicopathologic Role.
K-C Chang, H-L Song, C-H Huang, C Chang, Y-T Jin - National Cheng Kung University and Hospital, Tainan, Taiwan; Taiwan Adventist Hospital, Taipei, Taiwan
SYK Inhibition and Response Prediction in Diffuse Large B-Cell Lymphoma.
LY Wang, S Cheng, HX Zhang, R Shaknovich, Z Song, P Lu, A Pandey, G Coffey, U Sinha - Weill Cornell Medical College, New York, NY; Portola Pharmaceuticals Inc., South San Francisco, CA
ITK and SYK Genes Involved Chromosome Translocation in Peripheral T-Cell Lymphomas.
H Ye, W Zhang, B Li, G Dong, Y Zhou - Guilin Medical College, China; Hua Xi Hospital, Sichuan University, chengdu, China; Zhejiang University, Hangzhou, China; Tongren Hospital, Beijing, China
CD57+ Natural Killer Cells Are Associated with Better Overall Survival in DLBCL Patients.
JH Lee, YJ Kwak, CH Kim, I Kim - Korea University Anam Hospital, Seoul, Korea; College of Medicine, Korea University, Seoul, Korea
Mature B-Cell Lymphomas with Blastoid Morphology: Clinicopathologic and Genetic Features of 33 Cases.
R Kanagal Shamannna, LJ Medeiros, SA Wang, RN Miranda - UT MD Anderson Cancer Center, Houston
"Double Hit"High-Grade B-Cell Lymphomas: An Aggressive Disease with Heterogeneous Histologic Features and Clinical Outcome.
S Li, LJ Medeiros, LE Fayad, PA Lennon, CC Yin, P Lin - The University of Texas MD Anderson Cancer Center, Houston
Bright CD38 and Dim CD20 by Flow Cytometry May Predict for Double Hit Lymphomas in MYC Rearranged High-Grade B-Cell Lymphomas.
JS Willis, AC Seegmiller, N Uddin, NJ Karandikar, W Chen - UT Southwestern Medical Center, Dallas, TX